FEATURED COMPANIES
- Abbott Laboratories
- Artsana S.p.A
- B. Braun Melsungen AG
- BD
- Eli Lilly and Company
- Insulet Corporation
Diabetes is rising at an alarming rate in the United States. Diabetes referred to as diabetes mellitus, is a group of metabolic diseases in which a person suffers from high blood glucose. If diabetes is not appropriately monitored, then it can be fatal and cause serious health complications such as kidney diseases, heart diseases, amputation, stroke and blindness. Between the year 2000 and 2019, the number of people living with diabetes tripled and the number of new cases annually doubled in the United States. The United States represents the third-largest diabetes patient pool owing to the increasing geriatric population and rising obesity levels in 2018. The United States Diabetes Market is expected to reach USD 26.28 Billion by the year 2025.
The use of continuous glucose monitoring systems and continuous subcutaneous insulin infusion has gained full acceptance in diabetes care. These devices have been demonstrated to be clinically valuable, reducing risks of hypoglycemia and improving glycemic control in ambulatory patients with type 1 diabetes & type 2 diabetes. Because of this tremendous improvement in the number of patients, especially those requiring insulin therapy, the cost of healthcare-related to diabetes and its complications is ever increasing. The market of Insulin Pen, Insulin Pump, Continuous Glucose Monitoring (CGM) Device and Self Monitoring Blood Glucose Device are growing due to the rise in numbers of diabetic patients in the United States.
The increasing diabetes prevalence has led the U.S. government to raise awareness and prevention programs about its symptoms and encourage healthier lifestyle behaviour amongst citizens. In 2019, Abbott Laboratories planned to ramp up manufacturing capacity for its lower-cost continuous glucose monitor (CGM) device in the next few years, aiming to reach millions of more patients worldwide, According to Reuters, in March 2018, Sanofi-aventis U.S. LLC received approval from the U.S. Food and Drug Administration for Toujeo Max SoloStar.
This report provides a complete analysis of United States Insulin Delivery Devices Market.
Segments Market based on Devices
1. Continuous Glucose Monitoring (CGM)
2. Self Monitoring Blood Glucose (SMBG)
3. Insulin Pen
4. Insulin Pump
United States Diabetes Sub-Segment Analysis
1. Continuous Glucose Monitoring (CGM)
1. Glucose Sensor Market & Forecast
2. CGM Transmitter Market & Forecast
3. CGM User
4. CGM Reimbursement
2. SMBG
1. Test Strips Market and Forecast
2. Lancet Market and Forecast
3. Meter Market and Forecast
4. Blood Glucose (SMBG) Users
5. Blood Glucose Devices Reimbursement
3. Insulin Pen Market
1. Disposable Insulin Pen
2. Reusable Insulin Pen
3. Smart Insulin Pen
4. Insulin Pen Needle Market
5. Reimbursement Policies
4. Insulin Pump Market
1. Insulin Pump Market
2. USA (By States) - Diabetes Supplies
3. Reimbursement Policies by State-Sponsored Health Program
All the 11 Companies Studied in the Report have been Studied from 3 Points
- Company Overview
- Recent Developments
- Financial Insight
Company Analysis
1. B. Braun Melsungen AG
2. Eli Lilly and Company
3. Artsana S.p.A
4. BD
5. Novo Nordisk A/S
6. Owen Mumford Ltd
7. Ypsomed AG
8. Medtronic
9. Insulet Corporation
10. LifeScan Inc.
11. Abbott Laboratories
Key Benefits of the Report
- This report provides current market estimates and forecasts for the United States Diabetic Market.
- Detailed analysis of the key market segments such as source, geography and applications; provides a comprehensive understanding of the market.
- United States Diabetic Market - Growth Drivers and Challenges.
- Key sustainability strategies adopted by market players.
FEATURED COMPANIES
- Abbott Laboratories
- Artsana S.p.A
- B. Braun Melsungen AG
- BD
- Eli Lilly and Company
- Insulet Corporation
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Driver
4.1.1 Rising Diabetes Mellitus in an Aging Population
4.1.2 Rising prevalence of diabetes in various age groups
4.1.3 Rising Government Funding for Diabetes Management
4.1.4 Benefits of Insulin Pump over Multiple Daily Injection
4.1.5 Lifestyle-Compatible Treatment Options and Technological Advancement in Insulin Pump Devices
4.2 Challenges
4.2.1 Technological advancements in insulin infusion devices
4.2.2 Blood Glucose Meter Accuracy Problem
4.2.3 Low Compliance of Glucose Monitoring & Inadequate Reimbursement for SMBG Supplies
4.2.4 Safety Issues in Insulin Pump Devices
4.2.5 Difficulties Associated with the Pump
4.2.6 Adherence
5. United States Diabetes Market
6. United States Diabetes Population & Forecast
6.1 Type 1 Diabetes
6.2 Type 2 Diabetes
6.3 Type 1 & Type 2 Diabetes Population and Forecast
7. Market Share Analysis - United States Diabetic
7.1 By Types
8. Continuous Glucose Monitoring Market (CGM) - Market & Users
8.1 CGM Market by Components
8.1.1 Glucose Sensor Market
8.1.2 CGM Transmitter Market
8.2 CGM User
8.3 Reimbursement Policies of CGM Devices in United States
9. Blood Glucose Device (SMBG) - United States Market & Users
9.1 Market
9.1.1 Type 1 & Type 2 (Diabetes) SMBG Market
9.2 Test Strips Market
9.2.1 Type 1 & Type 2 (Diabetes)
9.3 Lancet Market and Forecast
9.3.1 Type 1 & Type 2 (Diabetes)
9.4 Meter Market and Forecast
9.4.1 Type 1 & Type 2 (Diabetes)
9.5 Blood Glucose (SMBG) Users
9.5.1 Type 1 & Type 2 (Diabetes)
9.6 Reimbursement Policies of Blood Glucose Devices in United States
10. Insulin Pen - United States Market & User
10.1 Insulin Pen User
10.1.1 Disposable Insulin Pen
10.1.2 Reusable Insulin Pen
10.1.3 Smart Insulin Pen
10.2 Insulin Pen Market
10.2.1 Disposable Insulin Pen
10.2.2 Reusable Insulin Pen
10.2.3 Smart Insulin Pen
10.3 Insulin Pen Needle Market
10.4 Reimbursement Policies of Insulin Pen in United States
11. Insulin Pump - United States Market & Users
11.1 Insulin Pump Market for Type 1 Diabetes
11.2 Insulin Pump Market for Type 2 Diabetes
11.3 Insulin Pump User
11.3.1 Insulin Pump User & Forecast
11.3.2 Type 1 & Type 2 (Insulin Pump User & Forecast)
11.4 Differentiation Points of Insulin Pump Products in United States
11.4.1 Animas Vibe
11.4.2 Medtronic 530G with Enlite
11.4.3 Insulet OmniPod
11.4.4 Tandem t: slim
11.4.5 Roche Accu-Chek Combo
11.5 Training Model for Patients & HCP - of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care
11.5.1 Medtronic
11.6 Insulet Corporation
11.6.1 Training Structure for New Patients - Insulet Corporation
11.7 Animas Corporation
11.7.1 Training Modules for New Patients
11.7.2 Training Modules for HCP (Health Care Professional)
11.8 Tandem Diabetes Care
11.9 USA (By States) - Diabetes Supplies, Insulin Pump & Pump Supplies Reimbursement Policies by State-Sponsored Health Program
11.9.1 CALIFORNIA
11.9.2 People Covered by Insurance Mandates
11.9.3 Equipment and Supplies
11.9.4 Services
11.9.5 DELAWARE
11.9.6 FLORIDA
11.9.7 MASSACHUSETTS
11.9.8 MICHIGAN
11.9.9 MONTANA
11.9.10 NEBRASKA
11.9.11 NEW JERSEY
11.9.12 NEW YORK
11.9.13 OKLAHOMA
11.9.14 RHODE ISLAND
11.9.15 SOUTH DAKOTA
11.9.16 Equipment and Supplies
11.9.17 Services
11.10 TENNESSEE
11.10.1 People Covered by Insurance Mandates
11.10.2 Equipment and Supplies
11.10.3 Services
11.11 TEXAS
11.11.1 People Covered by Insurance Mandates
11.11.2 Equipment and Supplies
11.11.3 Services:
11.12 WASHINGTON
11.12.1 People Covered by Insurance Mandates
11.12.2 Equipment and Supplies
11.12.3 Services
11.13 Top Private Insurer - Reimbursement Policy of Insulin Pump
11.13.1 Blue Cross and Blue Shield
11.13.2 Insulin Pump Reimbursement
11.14 Aetna
11.14.1 Insulin Pump Reimbursement
11.15 Cigna
11.15.1 Insulin Pump Coverage Policy
11.16 United Healthcare
11.16.1 Insulin Pump Reimbursement Policy
12. Insulin Pen - Company Analysis
12.1 B. Braun Melsungen AG
12.1.1 Overview
12.1.2 Initiatives & Recent Developments
12.1.3 Revenue
12.2 Eli Lilly
12.2.1 Overview
12.2.2 Initiatives & Recent Developments
12.2.3 Revenue
12.3 Artsana S.p.A.,
12.3.1 Overview
12.3.2 Initiatives & Recent Developments
12.3.3 Revenue
12.4 BD
12.4.1 Overview
12.4.2 Initiatives & Recent Developments
12.4.3 Revenue
12.5 Novo Nordisk A/S
12.5.1 Overview
12.5.2 Initiatives & Recent Developments
12.5.3 Revenue
12.6 Owen Mumford Ltd.
12.6.1 Overview
12.6.2 Initiatives & Recent Developments
12.6.3 Revenue
12.7 Ypsomed AG
12.7.1 Overview
12.7.2 Initiatives & Recent Developments
12.7.3 Revenue
13. Insulin Pump - Company Analysis
13.1 Medtronic
13.1.1 Overview
13.1.2 Insulin Pump - Product Details
13.1.3 Revenue
13.1.4 Insulin Pump - Latest Development & Trends
13.2 Insulet Corporation
13.2.1 Overview
13.2.2 Insulin Pump - Product Details
13.2.3 Revenue
14. SMBG - Company Analysis
14.1 LifeScan Inc.
14.1.1 Overview
14.1.2 LifeScan SMBG Revenue& Forecast
14.2 Abbott Laboratories
14.2.1 Business Overview
14.2.2 Abbott Laboratories SMBG Revenue & Forecast
15. CGM - Company Analysis
15.1 Dexcom Inc
15.1.2 Recent Development
15.1.3 Revenue& Forecast
15.2 Abbott Laboratories
15.2.1 Overview
15.2.2 Recent Development
15.3 Roche
15.3.1 Overview
15.3.2 Recent Development
List of Figures:
Figure 4-1: Global Ageing Population (Billion) 2015 - 2050
Figure 5-1: United States -Diabetic Market (Billion US$), 2013 - 2019
Figure 5-2: United States- Forecast for Market (Billion US$), 2020 - 2025
Figure 6-1: United States - Diabetic Population (Thousand), 2013 - 2019
Figure 6-2: Global - Forecast for Diabetic Population (Thousand), 2020 - 2025
Figure 6-3: United States - Type 1 & Type 2 Diabetes Population (Thousand), 2011 - 2019
Figure 6-4: United States - Forecast for Type 1 & Type 2 Diabetes Population (Thousand), 2020 - 2025
Figure 8-1: United States - CGM Market (Million US$), 2011 - 2019
Figure 8-2: United States - Forecast for CGM Market (Million US$), 2020 - 2025
Figure 8-3: United States - Glucose Sensor Market (Million US$), 2011 - 2019
Figure 8-4: United States - Forecast for Glucose Sensor Market (Million US$), 2020 - 2025
Figure 8-5: United States - CGM Transmitter Market (Million US$), 2011 - 2019
Figure 8-6: United States - Forecast for CGM Transmitter Market (Million US$), 2020 - 2025
Figure 8-7: United States - CGM User (Number), 2011 - 2019
Figure 8-8: United States - Forecast for CGM User (Number), 2020 - 2025
Figure 9-1: United States - Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2011 - 2019
Figure 9-2: United States - Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2020 - 2025
Figure 9-3: United States - Self-Monitoring of Blood Glucose Market by Type 1 & Type 2
Figure 9-4: United States - Forecast for Self-Monitoring of Blood Glucose Market Type 1 & Type 2
Figure 9-5: United States - Blood Glucose Test Strips Market (Million US$), 2011 - 2019
Figure 9-6: United States - Forecast for Blood Glucose Test Strips Market (Million US$), 2020 - 2025
Figure 9-7: United States - Blood Glucose Test Strips Market by Type 1 & Type 2
Figure 9-8: United States - Forecast for Blood Glucose Test Strips Market by Type 1 & Type 2
Figure 9-9: United States - Blood Glucose Lancet Market (Million US$), 2011 - 2019
Figure 9-10: United States - Forecast for Blood Glucose Lancet Market (Million US$), 2020 - 2025
Figure 9-11: United States - Blood Glucose Lancet Market by Type 1 & Type 2
Figure 9-12: United States - Forecast for Blood Glucose Lancet Market by Type 1 & Type 2
Figure 9-13: United States - Blood Glucose Meter Market (Million US$), 2011 - 2019
Figure 9-14: United States - Forecast for Blood Glucose Meter Market (Million US$), 2020 - 2025
Figure 9-15: United States - Blood Glucose Meter Market by Type 1 & Type 2 (Million US$), 2011 - 2019
Figure 9-16: United States - Forecast for Blood Glucose Meter Market by Type 1 & Type 2 (Million US$), 2020 - 2025
Figure 9-17: United States - Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2011 - 2019
Figure 9-18: United States - Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2020 - 2025
Figure 9-19: United States - Self-Monitoring of Blood Glucose (SMBG) Users by Type 1 & Type 2 (Thousand), 2011 - 2018
Figure 9-20: United States - Forecast for Self-Monitoring of Blood Glucose (SMBG) Users by Type 1 & Type 2 (Thousand), 2019 - 2025
Figure 10-1: United States - Insulin Pen Market (Million US$), 2011 - 2019
Figure 10-2: United States - Forecast for Insulin Pen Market (Million US$), 2020 - 2025
Figure 10-3: United States - Insulin Pen Users (Numbers), 2011 - 2019
Figure 10-4: United States - Forecast for Insulin Pen Users (Numbers), 2020 - 2025
Figure 10-5: United States - Disposable Insulin Pen Market (Million US$), 2011 - 2019
Figure 10-6: United States - Forecast for Disposable Insulin Pen Market (Million US$), 2020 - 2025
Figure 10-7: United States - Disposable Insulin Pen Users (Numbers), 2011 - 2019
Figure 10-8: United States - Forecast for Disposable Insulin Pen Users (Numbers), 2020 - 2025
Figure 10-9: United States - Reusable Insulin Pen Market (Million US$), 2011 - 2019
Figure 10-10: United States - Forecast for Reusable Insulin Pen Market (Million US$), 2020 - 2025
Figure 10-11: United States - Reusable Insulin Pen Users (Numbers), 2011 - 2019
Figure 10-12: United States - Forecast for Reusable Insulin Pen Users (Numbers), 2020 - 2025
Figure 10-13: United States - Smart Insulin Pen Market (Million US$), 2011 - 2019
Figure 10-14: United States - Forecast for Smart Insulin Pen Market (Million US$), 2020 - 2025
Figure 10-15: United States - Smart Insulin Pen Users (Numbers), 2011 - 2019
Figure 10-16: United States - Forecast for Smart Insulin Pen Users (Numbers), 2020 - 2025
Figure 10-17: United States - Insulin Pen Needle Market (Million US$), 2011 - 2019
Figure 10-18: United States - Forecast for Insulin Pen Needle Market (Million US$), 2020 - 2025
Figure 11-1: USA - Insulin Pump Market (US$ Million), 2011 - 2019
Figure 11-2: USA- Forecast for Insulin Pump Market (US$ Million), 2020 - 2025
Figure 11-3: United States - Insulin Pump Type 1 Market (Million US$), 2011 - 2019
Figure 11-4: United States - Forecast for Insulin Pump Type 1 Market (Million US$), 2020 - 2025
Figure 11-5: United States - Insulin Pump Type 2 Market (Million US$), 2011 - 2019
Figure 11-6: United States - Forecast for Insulin Pump Type 2 Market (Million US$), 2020 - 2025
Figure 12-1: Global - B. Braun Melsungen AG Revenue (Million US$), 2014 - 2019
Figure 12-2: Global - Forecast for B. Braun Melsungen AG Revenue (Million US$), 2020 - 2025
Figure 12-3: Global - Eli Lilly and Company Revenue (Million US$), 2014 - 2019
Figure 12-4: Global - Forecast for Eli Lilly and Company Revenue (Million US$), 2020 - 2025
Figure 12-5: Global - Artsana S.p.A. Revenue (Million US$), 2016 - 2019
Figure 12-6: Global - Forecast for Artsana S.p.A. Revenue (Million US$), 2020 - 2025
Figure 12-7: Global - Becton, Dickinson and Company Revenue (Million US$), 2014 - 2019
Figure 12-8: Global - Forecast for Becton, Dickinson and Company Revenue (Million US$), 2020 - 2025
Figure 12-9: Global - Novo Nordisk A/S Revenue (Million US$), 2015 - 2019
Figure 12-10: Global - Forecast for Novo Nordisk A/S Revenue (Million US$), 2020 - 2026
Figure 12-11: Global - Owen Mumford Ltd. Revenue (Million US$), 2011 - 2019
Figure 12-12: Global - Forecast for Owen Mumford Ltd. Revenue (Million US$), 2020 - 2026
Figure 12-13: Global - Ypsomed AG Revenue (Million US$), 2013 - 2019
Figure 13-1: Global - Medtronic Insulin Pump Revenue (Million US$), 2014 - 2019
Figure 13-2: Global - Forecast for Medtronic Insulin Pump Revenue (Million US$), 2019 - 2025
Figure 13-3: Global - Insulet Corporation Insulin Pump Revenue (Million US$), 2014 - 2019
Figure 13-4: Global - Forecast for Insulet Corporation Insulin Pump Revenue (Million US$), 2020 - 2025
Figure 14-1: Global - LifeScan SMBG Revenue (Million US$), 2014 - 2019
Figure 14-2: Global - Forecast for LifeScan SMBG Revenue (Million US$), 2020 - 2025
Figure 14-3: Global - Abbott Laboratories Diabetes Care Revenue (Million US$), 2014- 2019
Figure 14-4: Global - Forecast for Abbott Laboratories Diabetes Care Revenue (Million US$), 2020- 2025
List of Tables:
Table 4-4‑1: United States - Estimated Spending for Pre-diabetes and Diabetes by the Federal Governmentand States (US$ Billion), 2011 - 2020
Table 7‑1: United States - Diabetic Market Share by Types (Percent), 2013 - 2019
Table 7‑2: United States - Forecast for Diabetic Market Share by Types (Percent), 2020 - 2025
Table 8‑1: Features of Selected CGM Systems Available in the United States
Table 11‑1: United States - Animas Vibe Differentiation Features
Table 11‑2: United States - Medtronic 530G with Enlite Differentiation Features
Table 11‑3: United States - Insulet OmniPod Differentiation Features
Table 11‑4: United States - Tandem t: slim Differentiation Features
Table 11‑5: United States - Roche Accu-Chek Combo Differentiation Features
Table 11‑6: Blue Cross and Blue Shield - Comparison of Benefits between Standard Option and Basic Option
Table 11‑7: Blue Cross and Blue Shield - Insulin Pump Coverage
Table 13‑1: Medtronic - Latest Insulin Pump Products
Table 13‑2: Acquisitions by Medtronic
Table 13‑3: Insulet Corporation - Latest Products
Table 14‑1: Acquisitions by Abbott
- B. Braun Melsungen AG
- Eli Lilly and Company
- Artsana S.p.A
- BD
- Novo Nordisk A/S
- Owen Mumford Ltd
- Ypsomed AG
- Medtronic
- Insulet Corporation
- LifeScan Inc.
- Abbott Laboratories
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
